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A bstract Between 1970 and 1993, 
446 patients underwent pneumonec­
tomy. Completion pneumonectomy 
was performed in 37 patients (8.3%): 
34 men and 3 women, with a mean 
age of 61 years (range 20-78 years). 
Indications were benign disease in
4 patients and carcinoma in 33. Of 
the latter, 21 patients underwent re­
section for metachronous lung can­
cer, 6 for recurrent lung cancer, 4 for 
previous incomplete resection, 1 for 
primary lung cancer after previous 
resection for benign disease and 1 
patient after previous segmentec- 
tomy for metastasis. The mean 
interval between first operation and 
completion pneumonectomy was 
41 months (range 1-187 months) for 
the whole group, 30 months for be­
nign disease and 42 months for car­
cinoma. The overall operative mor­
tality was 6/37 (16.2%); 1/4 patients 
with benign disease and 5/33 
(15.2%) patients with carcinoma. 
Nine patients (29%) had one or more
major non-fatal complication. Actu­
arial 3- and 5-year survival rates 
were 41.0% and 24.5% for the entire 
group, 75% at both times for patients 
with benign disease, 36.4% and 
18.3% for all patients with carci­
noma at the time of completion 
pneumonectomy and 24.3% and 
14.5% for patients with metachro­
nous or recurrent lung cancer. For 15 
patients with stage I or II metachro­
nous lung cancer, the 3- and 5-year 
survival rates were 33.9% and 
16.9%. All six patients with stage III 
metachronous cancer died within 
18 months. In conclusion, comple­
tion pneumonectomy carries a high 
operative mortality and morbidity. 
Long-term survival is negatively in­
fluenced by stage III lung cancer. 
[Eur J Cardio-thorac Surg (1996) 
10:238-241]
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Introduction Material and methods
Pneumonectomy is a well known and frequently performed 
thoracic surgical procedure with a mortality rate of about 
7% [2], Only a few studies discussing the indications and 
results of completion pneumonectomy have appeared in 
the literature [3, 5, 8], In this report we analyze the inci­
dence, indications and results of 37 completion pneumo­
nectomies.
Between 1970 and 1993, 1638 patients underwent lung resection of 
whom 446 underwent pneumonectomy, including completion pneu­
monectomy in 37 patients (8.3%). In the latter group 34 were men and
3 women, with a mean age of 61 years (range 20-78 years) at the time 
of completion pneumonectomy. The indication for the first resection 
was benign lung disease in 5 patients and lung cancer in 31 patients. 
In one patient the initial indication was metastasectomy (Table 1).
Of the five patients with benign lung disease, three underwent a 
single resection before completion pneumonectomy (one bilobecto­
4
my, one lobectomy and segmentectomy and one lobectomy and 
wedge resection). Two patients underwent more than one thoraco­
tomy: one patient underwent segmentectomy initially, followed by 
completion lobectomy for bronchiectasis after 14 years. The other 
patient underwent segmentectomy for an open chest injury, followed 
by bilobectomy and a third thoracotomy for decortication because of 
empyema.
All 31 patients with lung cancer had a single initial resection. Ten 
patients underwent lobectomy on the left, and 14 on the right, side. 
Seven patients underwent bilobectomy of the right lower and mid­
dle lobe. There were no sleeve-resections in this group. Only two pa­
tients received postoperative radiation therapy. The single patient 
with pulmonary metastasis underwent three thoracotomies before left 
completion pneumonectomy: five wedge resections on the left side, 
followed by segmentectomy on the left side, followed by lobectomy 
on the right side.
Indications for completion pneumonectomy were benign disease 
in 4 patients and carcinoma in 33 patients, all staged according to 
the criteria of the New International Staging System for Lung Can­
cer [6 ]. In cases of carcinoma only those patients were considered 
for completion pneumonectomy who probably had no mediastinal 
lymph node invasion or distant metastasis. We routinely performed 
a computed tomography (CT) scan of the chest and upper abdomen 
and a technetium bone scan since they were available. We performed 
a mediastinoscopy in all patients who had not undergone this proce­
dure before. There were no repeat mediastinoscopies in this series. 
Since we used a CT scan, patients with suspected extensive lymph 
node involvement and a previous mediastinoscopy were excluded 
from operation. Pulmonary function was assessed by arterial blood 
gas samples, spirometry and, in some cases, perfusion scan. Arteri­
al blood gases had to be normal at rest and after exercise. The ex­
pected forced expiratory volume in 1 s after the operation had to be 
more than 1 1. We did not perform pulmonary artery catheterization. 
The patients were declared fit enough to undergo a completion pneu­
monectomy.
Twenty-one patients underwent resection for metachronous lung 
cancer, using the criteria defined by Martini [4] (13 stage I, 2 sta­
ge II, 6 stage Ilia). Six patients underwent resection for recurrent 
lung cancer (1 stage II, 1 stage Ilia, 2 stage Illb, 2 unknown), four 
patients for previous incomplete resection (2 stage I, 1 stage II,
1 stage Ilia), one patient for primary lung cancer (stage Illb) after 
previous resection for tuberculosis and the last patient for metastasis 
(Table 2). Unexpected N2 node status, discovered during the opera­
tion, was not a contraindication for resection and complete ipsilat- 
eral mediastinal lymph node dissection.
The mean interval between first operation and completion pneu­
monectomy was 41 months (range 1-187 months) for the entire 
group, 30 months for patients with benign disease and 42 months for 
patients with carcinoma at the time of completion pneumonectomy.
The operation was performed through a standard posterolateral 
thoracotomy. In 1/3 of the patients a subperiostal rib resection was 
performed to get sufficient access. Because of dense adhesions, the 
pneumonectomy was extrapleural in 2/3 of the patients. We had to 
deal with large blood losses, especially after a previous extrapleural 
resection. In nearly all patients the hilum was avoided because of ad­
hesions and the pulmonary vessels were ligated intrapericardially. 
However, in one patient the pericardial cavity was obliterated be­
cause o f  an intrapericardial initial resection and hilar dissection was 
impossible because of ligneous reaction due to lung abscess and em­
pyema. The hilum was controlled by complete cross-clamping and 
oversewn by interrupted sutures. The lateral serratus muscle was 
transposed into the right pleural cavity to reinforce the bronchial 
stump and to reduce the pleural cavity. In all other patients, includ­
ing the two patients irradiated after the first operation, we covered 
the bronchial stump either with viable surrounding tissues or with 
the pedicled pericardial fat pad.
Follow-up data at the end of this study were obtained from the 
referring pulmonary physician. Actuarial survival curves were cal-
Tablc 1 Indications for initial resection in 37 patients
Indication No. o f  patients
Benign disease (5)
Bronchiectasis 1
Aspergilloma 1
Tuberculosis 1
Traumatic 2
Lung c a n c e r (31)
Epidermoid carcinoma 24
Adenocarcinoma 5
Large cell carcinoma 1
Small cell carcinoma 1
Pulmonary metastasis (1)
Adrenal gland carcinoma 1
*
Table 2 Indications for completion pneumonectomy in 37 patients
Initial resection (n ) Completion pneumonectomy No. o f
patients
Benign disease 5 Bronchiectasis 2
Lung abscess 1
Hemoptysis 1
Primary lung cancer 1
Lung cancer 31 Metachronous cancer 21
Local recurrence 6
Incomplete previous
resection 4
Metastasis 1 Metastasis 1
culated by the Kaplan-Meier method. Deaths from all causes were
included.
Results
The overall postoperative mortality was 6/37 (16.2%). 
Mortality for patients with benign disease was 1/4. This 
patient developed a bronchopleural fistula after com ple­
tion pneumonectomy; the hilum had been controlled by 
complete cross-clamping and he died subsequently due to 
adult respiratory distress syndrome (ARDS). For patients 
with carcinomas the mortality rate was 5/33 (15.2%), Two 
patients died of ARDS, one of them having undergone a 
rethoracotomy because of hemorrhage. One patient died of 
respiratory insufficiency due to aspiration pneumonia and 
one patient died of cardiac insufficiency after myocardial 
infarction during the operation due to hemorrhage caused 
by a ruptured pulmonary vein. The last patient died of un­
controllable hemorrhage caused by left ventricular rupture 
due to cardiac herniation.
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Fig. 2 Survival for metachronous or recurrent cancer
Nine patients (29%) had one or more major non-fatal 
complication during or after the operation: two patients had 
rupture of the pulmonary artery and two patients under­
went rethoracotomy because of hemorrhage. 1 patient de­
veloped a bronchopleural fistula and empyema treated by 
thoracostomy and muscle flap closure of the fistula. An­
other patient developed an esophagopleural fistula and em ­
pyema, also managed by thoracostomy and a feeding gas­
trostomy. Two more patients developed empyema, one was 
treated by thoracostomy and the other by drainage-lavage. 
One patient was treated for bronchopneumonia. One pa- 
tient presented ventricular fibrillation during the operation 
and was successfully defibrillated, four patients had atrial 
fibrillation after the operation with hemodynamic conse­
quences despite digitalization.
The actuarial 3- and 5-year survival rates were 41.0% 
and 24.5% for the entire group, 75% at both times for pa­
tients with benign disease and 36.4% and 18.3% for all pa­
tients with carcinoma at the time of completion pneum o­
nectomy (Fig. 1). For 27 patients with metachronous or re­
current lung cancer the 3- and 5-year survival rates were 
24.3% and 14.5%, for 21 patients only with metachronous 
cancers 24.0% and 12.0%. For 15 patients with stage I or
II metachronous lung cancer these rates were 33.9% and 
16.9%. All six patients with stage III metachronous can­
cer died within 18 months (Fig. 2). The mean follow-up 
was 3 years and 7 months (range: 4 m onths-13 years and
5 months) and was complete for all 31 patients who sur­
vived completion pneumonectomy. At the end of this 
study three patients with benign disease and 6 of 28 pa­
tients with carcinoma were still alive, without evidence of 
any malignancy. Twenty-two patients died during follow- 
up: in 16 patients death was due to recurrent disease and/or 
metastasis. Two patients died because of respiratory insuf­
ficiency and two patients due to cardiac insufficiency. In 
two patients the cause of death was unknown.
Discussion
In our series the overall operative mortality was high 
(16.2%), more than twice the mortality rate of 6 .2 % for 
primary pneumonectomy reported by Ginsberg and the 
members of the Lung Cancer Study Group [2], but within 
the range of the participating hospitals (0% -25% ). M or­
tality was higher for patients with benign disease (25%) 
then for patients with cancer (15.2%). McGovern et al. [5] 
reported an overall mortality rate of 12.4% in 113 patients 
undergoing completion pneumonectomy: the mortality for 
lung cancer (n = 64) was 9.4%, for pulmonary métastasés 
( n ^ 20) 0% and for benign lung disease (rc = 29) 27.6%. In 
a series of 19 patients who underwent completion pneu­
monectomy after bronchial sleeve-resection Van Schil 
et al. [8] reported a mortality rate of 15.8%. Grégoire et al. 
[3] published an overall operative mortality of 10.0%; the 
mortality in 41 patients with lung cancer was 11.6% and 
in 19 patients with benign disease 5.9% for completion 
pneumonectomy.
In our series respiratory insufficiency and/or ARDS was 
a major cause of death. We used the same spirometric cri­
teria as we did for primary pneumonectomy, but the grav­
ity of the operative trauma and a more than normal need 
for transfusion were probably etiologic factors. Injury of 
great pulmonary vessels was a serious difficulty we en­
countered in three patients. It indicates that the ligneous 
reaction after the initial operation contributes to a raised 
operative risk, despite intrapericardial vessel control. 
When the pericardial cavity is obliterated, Deslauriers [1] 
suggests dividing the bronchus first and then ligating the
a
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pulmonary vessels, which was impossible in one of our pa­
tients. Finally we found empyema to be a frequent compli­
cation after completion pneumonectomy, as has been re­
ported by others, too [3, 5]. Utley [7] reported completion 
pneumonectomy and thoracoplasty, to obliterate the in­
fected thoracic space and to achieve bronchial closure, in 
three patients with bronchopleural fistula and fungal em­
pyema. Immediate thoracoplasty or muscle transposition 
might be a good option to prevent postpneumonectomy em­
pyema, especially in infectious cases, despite the additive 
operative trauma.
During follow-up of the patients with benign disease no 
one. died, but the 5-year survival rate for all patients with 
carcinoma at the time of completion pneumonectomy was
18.3% in our series. McGovern et al. [5] found a 5-year 
survival of 26.4% for all patients with lung cancer, despite 
30 of 64 patients with stage III lung cancer, who still had 
a 5-year survival of 13.8%. In our series all six patients 
with stage III metachronous lung cancer died within 
18 months.
In conclusion, completion pneumonectomy is a diffi­
cult operation with elevated postoperative morbidity and 
a high operative mortality. The patients seem to be at risk 
of developing ARDS and empyema. Nevertheless comple­
tion pneumonectomy offers a good prospect for long-term 
survival in patients with benign lung disease. In patients 
with lung carcinoma, long-term survival is negatively in­
fluenced by stage III lung cancer.
References
1. Deslauriers J (1988) Indications for 
completion pneumonectomy. Ann Tho- 
rac Surg 46:133
2. Ginsberg RJ, Hill LD, Eagan RT, Tho­
mas P, Mountain CF, Deslauriers J, Fry 
WA, Butz RO, Goldberg M, Waters PF, 
Jones DP, Pairolero P, Rubinstein L, 
Pearson GF (1983) Modern thirty-day 
operative mortality for surgical resec­
tions in lung cancer. J Thorac Cardio- 
vasc Surg 86:654-658
3. Grégoire J, Deslauriers J, Guojin L, 
Rouleau J (1993) Indications, risks, and 
results of completion pneumonectomy.
J Thorac Cardiovasc Surg 105:918-924
4. Martini N, Melamed MR (1975) Multi­
ple primary lung cancers, J Thorac Car­
diovasc Surg 70:606-612
5. McGovern EM, Trastek VF, Pairolero 
PC, Payne SW (1988) Completion 
pneumonectomy: indications, complica­
tions and results. Ann Thorac Surg 
46:141-146
6 . Mountain CF (1986) A new internation­
al staging system for lung cancer. Chest
89:225S-233S
7. Utley JR (1993) Completion pneum o­
nectomy and thoracoplasty for broncho 
pleural fistula and fungal empyema. 
Ann Thorac Surg 55:672-676
8 . Van Schil PE, Brutel de la Rivière A, 
Knaepen PJ, Van Swieten HA, Defauw 
JJ, Van den Bosch JM (1992) Com ple­
tion pneumonectomy after bronchial 
sleeve resection: incidence, indications 
and results. Ann Thorac Surg 
53:1042-1045
a
